Jason A. Call

426 total citations
18 papers, 288 citations indexed

About

Jason A. Call is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jason A. Call has authored 18 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Jason A. Call's work include Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (4 papers) and Meningioma and schwannoma management (3 papers). Jason A. Call is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (4 papers) and Meningioma and schwannoma management (3 papers). Jason A. Call collaborates with scholars based in United States, France and Spain. Jason A. Call's co-authors include Robert C. Miller, O. Kenneth Macdonald, Kenneth R. Olivier, Christopher M. Lee, Michael G. Haddock, Heather Bauer, Paul D. Brown, Bryan McIver, Robert L. Foote and Kyle J. Lafata and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Jason A. Call

17 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason A. Call United States 10 160 90 64 61 59 18 288
Michelle Gentile United States 9 101 0.6× 76 0.8× 31 0.5× 62 1.0× 56 0.9× 26 274
Christine H. Feng United States 12 122 0.8× 54 0.6× 12 0.2× 83 1.4× 37 0.6× 26 327
Douglas G. Gold United States 7 137 0.9× 137 1.5× 19 0.3× 98 1.6× 33 0.6× 10 323
Carolina E. Fasola United States 9 169 1.1× 99 1.1× 123 1.9× 130 2.1× 69 1.2× 25 364
Robyn Cheuk Australia 9 46 0.3× 50 0.6× 49 0.8× 74 1.2× 49 0.8× 26 322
Zeinab Abou Yehia United States 9 76 0.5× 49 0.5× 23 0.4× 87 1.4× 22 0.4× 39 315
Robin Schoenthaler United States 8 228 1.4× 155 1.7× 24 0.4× 124 2.0× 23 0.4× 12 388
Casely Ago Canada 6 140 0.9× 25 0.3× 28 0.4× 184 3.0× 41 0.7× 6 324
Jaymin Jhaveri United States 12 144 0.9× 66 0.7× 89 1.4× 105 1.7× 74 1.3× 19 325
S Korzeniowski Poland 11 125 0.8× 113 1.3× 10 0.2× 186 3.0× 75 1.3× 33 344

Countries citing papers authored by Jason A. Call

Since Specialization
Citations

This map shows the geographic impact of Jason A. Call's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason A. Call with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason A. Call more than expected).

Fields of papers citing papers by Jason A. Call

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason A. Call. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason A. Call. The network helps show where Jason A. Call may publish in the future.

Co-authorship network of co-authors of Jason A. Call

This figure shows the co-authorship network connecting the top 25 collaborators of Jason A. Call. A scholar is included among the top collaborators of Jason A. Call based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason A. Call. Jason A. Call is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Oliva, Marc, Sebastian Ochsenreither, C. Le Tourneau, et al.. (2024). 607O Interim results of a phase I study of SGN-PDL1V (PF-08046054) in patients with PDL1-expressing solid tumors. Annals of Oncology. 35. S486–S486. 5 indexed citations
3.
Atalar, Banu, Mahmut Özsahin, Jason A. Call, et al.. (2018). Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience. Radiotherapy and Oncology. 127(1). 96–102. 19 indexed citations
4.
Carlson, Jonathan D., Benjamin Ling, Aaron Wagner, et al.. (2016). Retrospective Study of Metastatic Melanoma and Renal Cell Carcinoma to the Brain with Multivariate Analysis of Prognostic Pre-Treatment Clinical Factors. International Journal of Molecular Sciences. 17(3). 400–400. 10 indexed citations
5.
Lamoreaux, Wayne T., A Mackay, Robert K. Fairbanks, et al.. (2015). Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient with Intracranial Metastatic Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 2015. 1–5. 2 indexed citations
6.
Call, Jason A., Brendan M. Prendergast, Lindsay G. Jensen, et al.. (2014). Intensity-modulated Radiation Therapy for Anal Cancer. American Journal of Clinical Oncology. 39(1). 8–12. 42 indexed citations
7.
Larson, Erik, Robert K. Fairbanks, Alex Mackay, et al.. (2014). Gamma Knife Treatment of Brainstem Metastases. International Journal of Molecular Sciences. 15(6). 9748–9761. 23 indexed citations
8.
Macdonald, O. Kenneth, et al.. (2014). Radiotherapy and Male Breast Cancer. American Journal of Clinical Oncology. 39(5). 458–462. 31 indexed citations
9.
Peacock, Justin G., Jason A. Call, & Kenneth R. Olivier. (2013). Radiotherapy for Metastatic Fibrolamellar Hepatocellular Carcinoma. Rare Tumors. 5(3). 101–102. 13 indexed citations
10.
Fairbanks, Robert K., Wayne T. Lamoreaux, A Mackay, et al.. (2013). Long-Term Survival and Improved Quality of Life following Multiple Repeat Gamma Knife Radiosurgeries for Recurrent Glioblastoma Multiforme: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2013. 1–5. 5 indexed citations
11.
Call, Jason A., et al.. (2013). A Role for Radiotherapy in the Management of Advanced Medullary Thyroid Carcinoma: the Mayo Clinic Experience. Rare Tumors. 5(3). 128–131. 25 indexed citations
12.
Fairbanks, Robert K., Wayne T. Lamoreaux, A Mackay, et al.. (2013). Gamma Knife Radiosurgery Treatment for Metastatic Melanoma of the Trigeminal Nerve and Brainstem: A Case Report and a Review of the Literature. SHILAP Revista de lepidopterología. 2013. 1–4. 3 indexed citations
13.
Call, Jason A., Scott L. Stafford, Ivy A. Petersen, & Michael G. Haddock. (2012). Use of Intraoperative Radiotherapy for Upper-extremity Soft-tissue Sarcomas. American Journal of Clinical Oncology. 37(1). 81–85. 17 indexed citations
14.
Call, Jason A., Michael G. Haddock, J. Fernando Quevedo, David W. Larson, & Robert C. Miller. (2012). Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center. Practical Radiation Oncology. 3(1). 26–31. 9 indexed citations
15.
Call, Jason A., Fausto J. Rodríguez, Caterina Giannini, et al.. (2012). Long-term Outcomes and Role of Chemotherapy in Adults With Newly Diagnosed Medulloblastoma. American Journal of Clinical Oncology. 37(1). 1–7. 19 indexed citations
16.
Stauder, Michael C., O. Kenneth Macdonald, Kenneth R. Olivier, et al.. (2011). Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiotherapy and Oncology. 99(2). 166–171. 57 indexed citations
17.
Call, Jason A., Michael G. Haddock, J. Fernando Quevedo, David W. Larson, & Robert C. Miller. (2011). Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: Efficacy of a low daily dose to clinically negative regions. Radiation Oncology. 6(1). 134–134. 7 indexed citations
18.
Call, Jason A., Scott L. Stafford, Ivy A. Petersen, & Michael G. Haddock. (2011). 17 poster USE OF INTRAOPERATIVE RADIATION THERAPY (IORT) FOR UPPER EXTREMITY SOFT TISSUE SARCOMAS: ANALYSIS OF DISEASE OUTCOMES AND TOXICITY. Radiotherapy and Oncology. 99. S10–S10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026